| 标题 |
Zamtocabtagene autoleucel, a tandem CD20–CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Peter Borchmann; Tom van Meerten; Gloria Iacoboni; Pierre Bories; Peter Dreger; et al 出版日期:2026-10-26 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)